9d
News Medical on MSNCD2AP and Alzheimer’s disease: A key regulator of neurodegeneration and potential therapeutic targetA comprehensive Thought Leaders Invited Review in Brain Medicine highlights the crucial role of CD2-associated protein (CD2AP ...
10d
The Mirror US on MSNTwo common herbs could be key to treating Alzheimer'sThe build-up of proteins associated with Alzheimer's were reduced by a plant compound which also lowered inflammation and ...
A protein that impacts Alzheimer’s disease offers new opportunities for targeted treatments, although its cell-specific ...
diseases driven by synapse loss and dysfunction. Boost Neuroscience was spun out of the Stanford University lab of Dr. Thomas Südhof, MD. Dr. Südhof was awarded the 2013 Nobel Prize in ...
Noise exposure is one of the most significant causes of synapse loss between inner hair cells and auditory nerve fibers, leading to a decline in hearing sensitivity.
Toxic Lipid Secretion: The ISR pathway in microglia was shown to drive the synthesis and release of harmful lipids that contribute to synapse loss, a hallmark of Alzheimer's disease. Therapeutic ...
In a new study, researchers have found that a new chemical compound derived from the herbs could help to combat Alzheimer's disease and provide a new approach to treating the condition in the future ...
Discover the trending cryptocurrency tokens on Avalanche today, including SYN, BNZ, and MYST, driving innovation and market ...
His team has begun experiments to test if the stimulatory impact of psychedelics on peripheral synapse formation has therapeutic potential to treat disorders such as hearing loss and neuropathies.
A new study has found that a compound that is derived from herbs - such as rosemary and sage - can help to reverse some of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results